# US 2010/0074937 A1 · Polyanhydrides with therapeutically useful degradation products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0074937 A1
- Document ID: US20100074937A1
- Status: Published application
- Kind: A1
- Application number: 12/428,088
- Filed: 2009-04-22
- Published: 2010-03-25
- Earliest claimed: 1997-09-10
- Assignees: Rutgers, The State University of New Jersey
- Inventors: Kathryn E. Uhrich
- Web page: https://patentgrep.com/patent/US20100074937A1

## CPC

- C08G 67/04: Polyanhydrides
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An aromatic polyanhydride comprising a repeating unit having the structure is disclosed, wherein Ar and R are selected so that the aromatic polyanhydride hydrolyzes to form a therapeutic salicylate, another non-steroidal anti-inflammatory, an antifibrotic aminobenzoate, or a vasoconstricting phenylethanolamine. Implantable medical devices, such as scaffolding implants for tissue reconstruction, drug delivery systems prepared from the aromatic polyanhydrides, as well as therapeutic dosage forms and treatment methods are also disclosed.

## Claims

### Claim at position 1

1-40. (canceled)

### Claim 41

An aromatic polyanhydride comprising a repeating unit having the structure:
wherein Ar and R are selected so that the aromatic polyanhydride hydrolyzes to form a therapeutic salicylate, another non-steroidal anti-inflammatory, an antifibrotic aminobenzoate, or a vasoconstricting phenylethanolamine.

### Claim 42 (depends on 41)

The aromatic polyanhydride of claim 41, wherein Ar and R are selected so that the aromatic polyanhydride hydrolyzes to form a therapeutic salicylate.

### Claim 43 (depends on 42)

The aromatic polyanhydride of claim 42, wherein the therapeutic salicylate is selected from the group consisting of thymotic acid, 4-sulfanilamidosalicylic acid, salicylsulfuric acid, salsalate, mesalamine, gentisic acid, enfenamic acid, salicylic acid, cresotic acid, aminosalicylic acid and aminophenylacetic acid.

### Claim 44 (depends on 43)

The aromatic polyanhydride of claim 43, wherein the therapeutic salicylate is salicylic acid.

### Claim 45 (depends on 41)

A drug delivery system comprising the aromatic polyanhydride of claim 41 physically admixed with a biologically or pharmaceutically active agent.

### Claim 46 (depends on 41)

A drug delivery system comprising a biologically or pharmaceutically active agent physically embedded or dispersed into a polymeric matrix formed from the aromatic polyanhydride of claim 41.

### Claim 47 (depends on 41)

A drug delivery system comprising a biologically or pharmaceutically active agent covalently bonded to the aromatic polyanhydride of claim 41.

### Claim 48 (depends on 41)

An implantable medical device comprising the aromatic polyanhydride of claim 41.

### Claim 49 (depends on 48)

The implantable medical device of claim 48, wherein said device is a scaffolding implant for tissue reconstruction.

### Claim 50 (depends on 41)

A method for site-specific or systemic drug delivery comprising implanting in the body of a patient in need thereof an implantable drug delivery device comprising a therapeutically effective amount of the aromatic polyanhydride of claim 41.

### Claim 51 (depends on 41)

A method for treating inflammation comprising administering to a patient in need thereof an effective amount of the aromatic polyanhydride of claim 41.

### Claim 52 (depends on 51)

The method of claim 51, wherein the aromatic polyanhydride is administered orally.

### Claim 53 (depends on 51)

The method of claim 51, wherein the inflammation is digestive inflammation.

### Claim 54 (depends on 51)

The method of claim 51, wherein the inflammation is caused by a digestive disorder.

### Claim 55 (depends on 54)

The method of claim 54, wherein the digestive disorder is a bowel disorder.

### Claim 56 (depends on 54)

The method of claim 54, wherein the digestive disorder is an inflammatory bowel disease.

### Claim 57 (depends on 54)

The method of claim 54, wherein the digestive disorder is Crohn's disease.

### Claim 58 (depends on 44)

A method for treating inflammation comprising orally administering to a patient in need thereof an effective amount of the aromatic polyanhydride of claim 44.

### Claim 59 (depends on 41)

A dosage form comprising an effective amount of the aromatic polyanhydride of claim 41 and a pharmaceutically acceptable excipient.

### Claim 60 (depends on 59)

The dosage form of claim 59 that is an oral dosage form.
